ESR1 and breast carcinoma: A total of 114 breast cancer patients were enrolled in this study, in order to analyze the relationship between TRIM28 expression level and clinicopathological parameters, including age, tumor size, vascular or nerve invasion condition, lymph node condition, histologic grade, TNM stage, ER, PR, Ki67, HER-2 expressions, and molecular subtype.